Released Aug 15, 2011, during market hours
10-Q filed Aug 15, 2011, 46 days after period end · 0001144204-11-047055
Q2 2011 · 10-Q
Revenue—
Net Income-$6.76K-$6.76K N/M vs Q2 2010N/M vs Q1 2011
EPS Diluted$0.00$0.00 — vs Q2 2010no prior Q1 2011 on file
Operating Income-$5,862N/M
Operating Cash Flowderived-$15,404—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$6.76K | -$5.58K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR